Lux Biosciences' Debt - II Round

Lux Biosciences raised a round of funding on July 14, 2011.

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of medications for serious ophthalmic diseases. With a product in NDA/MAA submission sta…

Articles about Lux Biosciences' Debt - II Round: